Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sipai Health Technology Co's EBIT per Share for the
six
months ended in Dec. 2025 was HK$-0.08.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 69.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 28.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sipai Health Technology Co's EBIT per Share or its related term are showing as below:
HKSE:00314'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -146.6 Med: 18.55 Max: 69.7
Current: 69.7
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Sipai Health Technology Co was 69.70% per year. The lowest was -146.60% per year. And the median was 18.55% per year.
HKSE:00314's 3-Year EBIT Growth Rate is ranked better than 92.38% of 105
companies
in the Medical Distribution industry
Industry Median: 2.7
vs HKSE:00314: 69.70
Sipai Health Technology Co (HKSE:00314) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sipai Health Technology Co EBIT per Share Related Terms
Sipai Health Technology Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co (HKSE:00314) has a EBIT per Share of HK$-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sipai Health Technology Co and its competitors. According to the industry distribution chart, Sipai Health Technology Co ranks #8 out of 105 companies in the Medical Distribution industry, placing it in the top 7.6%.
Is Sipai Health Technology Co's EBIT per Share too high?
Sipai Health Technology Co's current EBIT per Share is HK$-0.01. Based on the distribution chart, Sipai Health Technology Co ranks #8 out of 105 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sipai Health Technology Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's EBIT per Share compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #8 out of 105 companies for EBIT per Share. This places Sipai Health Technology Co in the top 8% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 2.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 2.70, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median EBIT per Share is 2.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current EBIT per Share is HK$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Sipai Health Technology Co (HKSE:00314) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.37, compared to a current price of HK$1.57 — trading 34% below its estimated fair value. The current EBIT per Share is HK$-0.01. Sipai Health Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sipai Health Technology Co (HKSE:00314), the current EBIT per Share is HK$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of HK$1.57 is trading 34% below its estimated GF Value™ of HK$2.37.
GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.
Key valuation signals for HKSE:00314:
EBIT per Share: HK$-0.01
GF Value™: HK$2.37 vs. price of HK$1.57 (34% below fair value)
No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
60GF Score
Get the complete analysis for HKSE:00314
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00314 has been successfully added to your 
